◄ back to all posts
Financial data and stock pages provided by
Fintel.io
#MacroView: Rates, The Dollar & The 2021 Outlook
Jun 11, 2021
#WhatYouMissed On RIA This Week: 06-11-21
Jun 11, 2021
◄ back to all posts
PFE: Pfizer Inc. Stock
Written by | Jul 6, 2018
SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 219,989.37 |
| Enterprise Value ($M) | 257,489.37 |
| Book Value ($M) | 68,620.00 |
| Book Value / Share | 12.26 |
| Price / Book | 3.21 |
| NCAV ($M) | -50,420.00 |
| NCAV / Share | -9.01 |
| Price / NCAV | -4.36 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.14 |
| Return on Assets (ROA) | 0.06 |
| Return on Equity (ROE) | 0.15 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.16 |
| Current Ratio | 1.48 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 39,533.00 |
| Assets | 158,818.00 |
| Liabilities | 89,953.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | n/a |
| Net Income | 9,652.00 |
| Earnings Per Share Diluted | 1.71 |
| Earnings Per Share Basic | 1.73 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 14,403.00 |
| Cash from Investing | -4,271.00 |
| Cash from Financing | -4,271.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | State Street Corp | 5.03 | -4.37 | |
| 13G/A | Vanguard Group Inc | 8.06 | -0.44 | |
| 13G/A | BlackRock Inc. | 7.10 | -6.86 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 4, 2021 ☐ TRANSITION REPORT PURSUANT TO S | ||
| Annual Report – 10-K | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,631,655 | 19,571,600 | 13.45 | |
| 1,708,984 | 19,176,700 | 8.91 | |
| 3,159,915 | 20,201,200 | 15.64 | |
| 2,112,629 | 23,402,100 | 9.03 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| NVS – Novartis AG | OGN – Organon & Co. |
| PBH – Prestige Brands Holdings, Inc. | PRGO – Perrigo Company PLC |
| QGEN – QIAGEN N.V. |
Financial data and stock pages provided by
Fintel.io
2018/07/06
Also Read
